The landscape of dementia diagnosis has advanced substantially with the appearance of refined biomarkers, together with amyloid PET scans, tau imaging, and blood-primarily based assessments that will detect Alzheimer's pathology several years before indicators arise. Though these technological improvements depict outstanding development in comprehe